Publishing Service

Polishing & Checking

Journal of Zhejiang University SCIENCE B

ISSN 1673-1581(Print), 1862-1783(Online), Monthly

FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of FOXO1/miR-506/ETS1/FOXO1

Abstract: To explore the role of forkhead box protein O1 (FOXO1) in the progression of glioblastoma multiforme (GBM) and related drug resistance, we deciphered the roles of FOXO1 and miR-506 in proliferation, apoptosis, migration, invasion, autophagy, and temozolomide (TMZ) sensitivity in the U251 cell line using in vitro and in vivo experiments. Cell viability was tested by a cell counting kit-8 (CCK8) kit; migration and invasion were checked by the scratching assay; apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining and flow cytometry. The construction of plasmids and dual-luciferase reporter experiment were carried out to find the interaction site between FOXO1 and miR-506. Immunohistochemistry was done to check the protein level in tumors after the in vivo experiment. We found that the FOXO1-miR-506 axis suppresses GBM cell invasion and migration and promotes GBM chemosensitivity to TMZ, which was mediated by autophagy. FOXO1 upregulates miR-506 by binding to its promoter to enhance transcriptional activation. MiR-506 could downregulate E26 transformation-specific 1 (ETS1) expression by targeting its 3'-untranslated region (UTR). Interestingly, ETS1 promoted FOXO1 translocation from the nucleus to the cytosol and further suppressed the FOXO1-miR-506 axis in GBM cells. Consistently, both miR-506 inhibition and ETS1 overexpression could rescue FOXO1 overactivation-mediated TMZ chemosensitivity in mouse models. Our study demonstrated a negative feedback loop of FOXO1/miR-506/ETS1/FOXO1 in GBM in regulating invasiveness and chemosensitivity. Thus, the above axis might be a promising therapeutic target for GBM.

Key words: Glioblastoma; Forkhead box protein O1 (FOXO1); MiR-506; E26 transformation specific-1 (ETS1); Chemosensitivity

Chinese Summary  <16> FOXO1/miR-506/ETS1/FOXO1环路抑制胶质母细胞瘤侵袭性并促进替莫唑胺化疗敏感性

陈超1,刘玉娥2,王洪祥1,张旭1,施裕丰2,陈菊祥1
1海军军医大学第一附属医院神经外科,中国上海市,200433
2同济大学医学院第十人民医院肿瘤中心,中国上海市,200092
摘要:为了探索FOXO1在胶质母细胞瘤(GBM)进展和化疗耐药中的作用和机制,本研究采用体外细胞学实验和动物实验分析FOXO1和miR-506对GBM细胞系U251增殖、凋亡、迁移、侵袭、自噬和替莫唑胺(TMZ)化疗敏感性的影响,并通过双荧光素酶报告实验分析FOXO1与miR-506相互作用的靶点。结果显示:FOXO1-miR-506轴可抑制GBM细胞侵袭和迁移能力,并促进其对TMZ的化疗敏感性,且自噬参与其中;FOXO1作为转录因子可与miR-506启动子区域相结合并上调其表达;此外,miR-506可结合在E26转录因子-1(ETS-1)3’-UTR区并下调ETS1表达,而ETS1可促进FOXO1从细胞核向细胞浆转移进而抑制FOXO1-miR-506轴。裸鼠动物实验结果显示,过表达FOXO1可促进GBM对TMZ的化疗敏感性,但miR-506抑制剂和过表达ETS1均可逆转该现象。综上所述,FOXO1/miR-506/ETS1/FOXO1环路参与GBM侵袭性和化疗敏感性的调节,可作为GBM治疗的潜在靶点。

关键词组:胶质母细胞瘤;FOXO1;MiR-506;E26转录因子-1(ETS-1);化疗敏感性


Share this article to: More

Go to Contents

References:

<Show All>

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





DOI:

10.1631/jzus.B2200503

CLC number:

Download Full Text:

Click Here

Downloaded:

812

Download summary:

<Click Here> 

Downloaded:

242

Clicked:

733

Cited:

0

On-line Access:

2023-08-08

Received:

2022-10-25

Revision Accepted:

2023-03-22

Crosschecked:

2023-08-08

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952276; Fax: +86-571-87952331; E-mail: jzus@zju.edu.cn
Copyright © 2000~ Journal of Zhejiang University-SCIENCE